Fourth Dimension Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.04M Sell
2,214
-120
-5% -$122K 0.77% 33
2025
Q4
$2.51M Hold
2,334
0.92% 31
2025
Q3
$1.78M Sell
2,334
-52
-2% -$38.7K 0.68% 39
2025
Q2
$1.86M Buy
2,386
+808
+51% +$628K 0.79% 36
2025
Q1
$1.3M Buy
1,578
+318
+25% +$265K 0.63% 39
2024
Q4
$973K Buy
+1,260
New +$1.04M 0.51% 39

Other funds holding LLY

Fourth Dimension Wealth's LLY Position: Q1 2026 in Review

Fourth Dimension Wealth reduced its Eli Lilly (LLY) stake by 5.1% in Q1 2026, selling an estimated $122K and leaving 2,214 shares worth $2.04M. The position accounts for 0.77% of the portfolio, ranked #33.

Fourth Dimension Wealth first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.51M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fourth Dimension Wealth held 2,214 shares of Eli Lilly worth $2.04M as of Q1 2026.
  • Fourth Dimension Wealth sold 120 Eli Lilly shares in Q1 2026, an estimated $122K.
  • Eli Lilly made up 0.77% of Fourth Dimension Wealth's portfolio in Q1 2026, its #33 holding.
  • Fourth Dimension Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Fourth Dimension Wealth's Eli Lilly position peaked at $2.51M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fourth Dimension Wealth's 13F filing for Q1 2026, filed 11 May 2026.